FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2978000113> ?p ?o ?g. }

• W2978000113 endingPage "084" @default.
• W2978000113 startingPage "077" @default.
• W2978000113 abstract "Tanjin is an herbal medicine made from the root of salvia miltiorrhiza. It is predominantly given to arteriosclerotic patients as a supplement to ameliorate the clinical symptoms of cardiovascular diseases. In China, tanjin is used frequently in combination treatment for hypercholesterolemia. Thus, there is a high probability of combination of tanjin and statins in these arteriosclerotic patients. This study investigated the interaction between tanjin and rosuvastatin.We performed a randomized single-blind, two-period crossover clinical trial on six healthy male volunteers. Volunteers were administered rosuvastatin with placebo or a tanjin-containing drug randomly. The blood samples were collected before drug administration, and at 0.5, 1, 1.5, 2, 4, 8, and 12 hours after administration. Lymphocytes were isolated from blood samples before and 12 hours after drug administration to measure mRNA. As an animal experiment, an in situ intestinal injection with portal vein sampling model was used to examine the interaction between tanjin and rosuvastatin during the absorption phase. Rosuvastatin or rosuvastatin combined with tanjin solution was injected into the intestine. After injection, blood from the portal vein was collected and the concentration of rosuvastatin was measured by LC/MS/MS analysis. A portion of the intestine and liver from the rats was collected and stored at -80°C for mRNA measurement.In the clinical trial, co-administration of tanjin decreased the maximum plasma concentration (Cmax) of rosuvastatin by 26.85% compared with rosuvastatin alone, and also decreased the area under the plasma concentration-time curve of rosuvastatin from 0 to 12 h (AUC0-12) by 19.43%. The relative expression of BCRP and OATP mRNA in human lymphocytes was increased by co-administration of tanjin. In the animal experiment, co-administration of tanjin extract reduced the concentration of rosuvastatin to 84.4, 64.4, and 50.0% at 15, 30, and 45 minutes, respectively. The tanjin-containing drug had a similar effect to tanjin extract. Furthermore, tanjin significantly reduced the absorption of rosuvastatin and the inhibitory effects lasted for at least 24 hours. Tanjin increased the relative expression of BCRP mRNA in the intestine, but it did not change the expression of OATP. Moreover, the concentration of rosuvastatin in the portal vein and systemic blood was reduced. In the liver, tanjin increased both BCRP and OATP mRNA expression, which was consistent with the results from human lymphocytes.The clinical trial and animal experiment revealed that tanjin can significantly reduce the absorption of rosuvastatin. This interaction occurred, at least, at the absorption phase in the small intestine due to the enhanced efflux transport. Thus, as tanjin and rosuvastatin were found to interact, their combination needs to be paid attention to." @default.
• W2978000113 created "2019-10-10" @default.
• W2978000113 creator A5025547247 @default.
• W2978000113 creator A5039215626 @default.
• W2978000113 creator A5049196605 @default.
• W2978000113 creator A5059560887 @default.
• W2978000113 creator A5076296879 @default.
• W2978000113 creator A5079310832 @default.
• W2978000113 date "2019-01-01" @default.
• W2978000113 modified "2023-10-14" @default.
• W2978000113 title "Pharmacokinetic Drug Interaction Between Rosuvastatin and Tanjin in Healthy Volunteers and Rats" @default.
• W2978000113 cites W1607804102 @default.
• W2978000113 cites W1963958736 @default.
• W2978000113 cites W1969753954 @default.
• W2978000113 cites W1999164183 @default.
• W2978000113 cites W2005954781 @default.
• W2978000113 cites W2022507089 @default.
• W2978000113 cites W2023718953 @default.
• W2978000113 cites W2038338711 @default.
• W2978000113 cites W2046057128 @default.
• W2978000113 cites W2068920819 @default.
• W2978000113 cites W2083924223 @default.
• W2978000113 cites W2084469971 @default.
• W2978000113 cites W2103068347 @default.
• W2978000113 cites W2119438401 @default.
• W2978000113 cites W2132599032 @default.
• W2978000113 cites W2135677264 @default.
• W2978000113 cites W2136466059 @default.
• W2978000113 cites W2151677618 @default.
• W2978000113 cites W2160313369 @default.
• W2978000113 cites W2316183519 @default.
• W2978000113 cites W2404245748 @default.
• W2978000113 cites W2412206485 @default.
• W2978000113 cites W2531924524 @default.
• W2978000113 cites W2723369878 @default.
• W2978000113 cites W2750012546 @default.
• W2978000113 cites W2761035018 @default.
• W2978000113 cites W2766987193 @default.
• W2978000113 cites W2791667455 @default.
• W2978000113 cites W2921771738 @default.
• W2978000113 doi "https://doi.org/10.33160/yam.2019.03.011" @default.
• W2978000113 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6437397" @default.
• W2978000113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30962748" @default.
• W2978000113 hasPublicationYear "2019" @default.
• W2978000113 type Work @default.
• W2978000113 sameAs 2978000113 @default.
• W2978000113 citedByCount "6" @default.
• W2978000113 countsByYear W29780001132019 @default.
• W2978000113 countsByYear W29780001132020 @default.
• W2978000113 countsByYear W29780001132022 @default.
• W2978000113 crossrefType "journal-article" @default.
• W2978000113 hasAuthorship W2978000113A5025547247 @default.
• W2978000113 hasAuthorship W2978000113A5039215626 @default.
• W2978000113 hasAuthorship W2978000113A5049196605 @default.
• W2978000113 hasAuthorship W2978000113A5059560887 @default.
• W2978000113 hasAuthorship W2978000113A5076296879 @default.
• W2978000113 hasAuthorship W2978000113A5079310832 @default.
• W2978000113 hasBestOaLocation W29780001131 @default.
• W2978000113 hasConcept C112705442 @default.
• W2978000113 hasConcept C126322002 @default.
• W2978000113 hasConcept C126894567 @default.
• W2978000113 hasConcept C142724271 @default.
• W2978000113 hasConcept C188947578 @default.
• W2978000113 hasConcept C204787440 @default.
• W2978000113 hasConcept C22979827 @default.
• W2978000113 hasConcept C27081682 @default.
• W2978000113 hasConcept C2776332195 @default.
• W2978000113 hasConcept C2777056448 @default.
• W2978000113 hasConcept C2780035454 @default.
• W2978000113 hasConcept C2780499067 @default.
• W2978000113 hasConcept C2908737378 @default.
• W2978000113 hasConcept C2988731192 @default.
• W2978000113 hasConcept C71924100 @default.
• W2978000113 hasConcept C87813604 @default.
• W2978000113 hasConcept C90924648 @default.
• W2978000113 hasConcept C98274493 @default.
• W2978000113 hasConceptScore W2978000113C112705442 @default.
• W2978000113 hasConceptScore W2978000113C126322002 @default.
• W2978000113 hasConceptScore W2978000113C126894567 @default.
• W2978000113 hasConceptScore W2978000113C142724271 @default.
• W2978000113 hasConceptScore W2978000113C188947578 @default.
• W2978000113 hasConceptScore W2978000113C204787440 @default.
• W2978000113 hasConceptScore W2978000113C22979827 @default.
• W2978000113 hasConceptScore W2978000113C27081682 @default.
• W2978000113 hasConceptScore W2978000113C2776332195 @default.
• W2978000113 hasConceptScore W2978000113C2777056448 @default.
• W2978000113 hasConceptScore W2978000113C2780035454 @default.
• W2978000113 hasConceptScore W2978000113C2780499067 @default.
• W2978000113 hasConceptScore W2978000113C2908737378 @default.
• W2978000113 hasConceptScore W2978000113C2988731192 @default.
• W2978000113 hasConceptScore W2978000113C71924100 @default.
• W2978000113 hasConceptScore W2978000113C87813604 @default.
• W2978000113 hasConceptScore W2978000113C90924648 @default.
• W2978000113 hasConceptScore W2978000113C98274493 @default.
• W2978000113 hasIssue "1" @default.
• W2978000113 hasLocation W29780001131 @default.
• W2978000113 hasLocation W29780001132 @default.
• W2978000113 hasLocation W29780001133 @default.

• next